Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer

doi:10.12998/wjcc.v10.i12.3698

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2796)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-7) series.

Item

Count

PDF

192

WORD

HTML

1524

Figures (1-2)

211

Tables (1-7)

217

Sum=2204

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

177

Download

415

Sum=592

Apr 26, 2022 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Apr 26, 2022; 10(12): 3698-3708
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698

Table 6 Comparison of tumor markers before and after chemotherapy between the two groups (mean ± SD)

Group	Cases	CEA (mg/L)		CA19-9 (kU/L)		CA125 (kU/L)
Group	Cases	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group	60	38.49 ± 6.12	11.40 ± 2.32^a	50.30 ± 12.21	19.92 ± 3.42^a	163.30 ± 34.43	54.30 ± 12.28^a
control group	58	40.02 ± 7.05	20.24 ± 2.50^a	52.29 ± 11.73	28.38 ± 2.95^a	168.29 ± 37.71	79.10 ± 14.42^a
t		-1.260	-19.919	-0.902	-14.368	-0.751	-10.070
P value		0.210	0.000	0.369	0.000	0.454	0.000

^aP < 0.05 vs before treatment.

CA: Cancer antigen; CEA: carcinoembryonic antigen.

Citation: Ding F, Chen RY, Hou J, Guo J, Dong TY. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3698